Market cap
₹230 Cr
Revenue (TTM)
₹611 Cr
P/E Ratio
7.3
P/B Ratio
1.3
Div. Yield
0.7 %
| IVP | Atul | DCM Shriram | EID Parry | Neogen Chemicals | |
|---|---|---|---|---|---|
Market cap (₹ Cr) |
230 | 17,927 | 15,348 | 12,476 | 7,086 |
Revenue (₹ Cr) |
611 | 6,643 | 14,593 | 38,840 | 926 |
Net Profit (₹ Cr) |
31.51 | 804.37 | 1,434.33 | 1,227.53 | 35.13 |
Net Margin (%) |
5.12 | 11.74 | 9.69 | 3.14 | 3.76 |
RoE (%) |
21.16 | 13.10 | 16.37 | 16.62 | 4.40 |
Price to Earnings |
7.30 | 22.54 | 10.71 | 26.84 | 199.26 |
Price-To-Book |
1.34 | 2.77 | 1.83 | 1.38 | 4.44 |
Income Statement (₹ Cr)
| IVP | Atul | DCM Shriram | EID Parry | Neogen Chemicals | |
|---|---|---|---|---|---|
|
Operating Revenue
|
611.09 | 6,643.49 | 14,593.40 | 38,839.87 | 925.53 |
|
Total Income
|
615.40 | 6,853.46 | 14,795.13 | 39,129.45 | 934.35 |
|
Total Expenditure
|
560.05 | 5,454.66 | 13,063.01 | 35,444.92 | 771.53 |
|
EBITDA
|
51.04 | 1,188.83 | 1,530.39 | 3,394.95 | 154.00 |
|
Depreciation
|
6.05 | 318.18 | 519.19 | 830.24 | 29.94 |
|
EBIT
|
44.99 | 870.65 | 1,011.20 | 2,564.71 | 124.06 |
|
Interest
|
6.64 | 16.91 | 172.71 | 465.10 | 83.27 |
|
Other Income
|
4.31 | 209.97 | 201.73 | 289.58 | 8.82 |
|
Exceptional Items
|
-0.46 | 0.00 | 56.03 | -478.38 | 0.00 |
|
Profit before Tax
|
42.20 | 1,063.71 | 1,096.25 | 1,910.81 | 49.61 |
|
Provision for Tax
|
10.69 | 259.34 | -338.08 | 683.28 | 14.48 |
|
Profit after Tax
|
31.51 | 804.37 | 1,434.33 | 1,227.53 | 35.13 |
Liabilities (₹ Cr)
| IVP | Atul | DCM Shriram | EID Parry | Neogen Chemicals | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
157.09 | 6,221.96 | 7,711.97 | 8,766.12 | 816.25 |
|
Minority Interest
|
0.00 | -15.53 | -2.78 | -762.63 | 0.00 |
|
Non-Current Liabilities
|
1.32 | 481.91 | 2,678.72 | 1,126.98 | 897.95 |
|
Current Liabilities
|
183.67 | 1,122.05 | 3,725.20 | 13,207.34 | 1,187.67 |
|
Total Liabilities
|
375.14 | 8,031.35 | 16,276.68 | 29,211.55 | 2,901.87 |
Assets (₹ Cr)
| IVP | Atul | DCM Shriram | EID Parry | Neogen Chemicals | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
68.04 | 3,738.40 | 8,228.02 | 9,527.28 | 1,268.64 |
|
Current Assets
|
270.69 | 4,055.60 | 5,564.08 | 18,746.53 | 1,392.51 |
|
Total Assets
|
375.14 | 8,031.35 | 16,276.68 | 29,211.55 | 2,901.87 |
|
Total Debt*
|
65.37 | 179.76 | 2,812.49 | 2,854.14 | 1,329.89 |
|
Net Current Assets
|
87.02 | 2,933.55 | 1,838.88 | 5,539.19 | 204.84 |
|
Contingent Liabilities
|
94.46 | 162.71 | 78.08 | 497.03 | 156.69 |
Cashflow (₹ Cr)
| IVP | Atul | DCM Shriram | EID Parry | Neogen Chemicals | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
52.71 | 1,022.77 | 1,233.80 | 1,541.51 | -231.48 |
|
Cash Flow from Investing Activities
|
-2.56 | -894.55 | -1,240.63 | -173.91 | -410.26 |
|
Cash from Financing Activities
|
-48.09 | -98.46 | -306.83 | -550.88 | 641.71 |
|
Net Cash Inflow / Outflow
|
2.06 | 29.76 | -313.66 | 816.72 | -0.03 |
Ratios
Profitability Ratios
| IVP | Atul | DCM Shriram | EID Parry | Neogen Chemicals | |
|---|---|---|---|---|---|
|
ROCE (%)
|
13.95 | 15.05 | 11.72 | 23.60 | 6.64 |
|
ROE (%)
|
21.16 | 13.10 | 16.37 | 16.62 | 4.40 |
|
ROA (%)
|
9.14 | 10.80 | 10.68 | 4.58 | 1.51 |
|
EBIT Margin (%)
|
7.36 | 13.11 | 6.93 | 6.60 | 13.40 |
|
Net Margin (%)
|
5.12 | 11.74 | 9.69 | 3.14 | 3.76 |
|
Cash Profit Margin (%)
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Growth Ratios
| IVP | Atul | DCM Shriram | EID Parry | Neogen Chemicals | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
13.39 | 15.75 | 11.20 | 15.66 | 18.00 |
|
EBIT Growth (%)
|
167.96 | 44.40 | 6.38 | 5.20 | 12.50 |
|
Net Profit Growth (%)
|
247.41 | 57.96 | 132.17 | -40.10 | 5.15 |
|
EPS Growth (%)
|
251.21 | 59.14 | 97.98 | 60.42 | -18.73 |
|
Book Value Growth (%)
|
12.75 | 11.14 | 10.11 | 10.53 | 3.41 |
Valuation Ratios
| IVP | Atul | DCM Shriram | EID Parry | Neogen Chemicals | |
|---|---|---|---|---|---|
|
Price / Earnings
|
7.22 | 22.54 | 12.56 | 8.62 | 178.10 |
|
Price / Book Value
|
1.34 | 2.77 | 1.83 | 1.38 | 4.44 |
|
Dividend Yield (%)
|
0.67 | 0.49 | 1.14 | 0.00 | 0.04 |
|
EV/EBITDA
|
5.72 | 13.76 | 11.27 | 3.53 | 54.61 |
|
Market Cap (₹ Cr)
|
114.93 | 18,762.28 | 17,435.78 | 13,791.35 | 2,933.68 |
Solvency Ratios
| IVP | Atul | DCM Shriram | EID Parry | Neogen Chemicals | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.00 | 0.03 | 0.21 | 0.02 | 1.00 |
|
Short term debt to equity ratio
|
0.42 | 0.00 | 0.13 | 0.29 | 0.51 |
|
Current Ratio
|
1.47 | 3.61 | 1.49 | 1.42 | 1.17 |
|
Quick Ratio
|
1.07 | 2.89 | 0.66 | 0.76 | 0.69 |
|
Interest Coverage
|
7.36 | 63.90 | 7.35 | 5.11 | 1.60 |
Operating Efficiency Ratios
| IVP | Atul | DCM Shriram | EID Parry | Neogen Chemicals | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
30.49 | 19.13 | 7.41 | 6.08 | 41.10 |
|
Asset Turnover
|
1.77 | 0.89 | 1.09 | 1.45 | 0.40 |
|
Receivable days
|
113.10 | 67.96 | 24.70 | 19.51 | 122.62 |
|
Inventory Days
|
48.29 | 43.79 | 72.95 | 72.68 | 185.31 |
|
Payable days
|
78.97 | 80.97 | 62.67 | 42.60 | 275.96 |
|
Cash Conversion Cycle
|
82.42 | 30.78 | 34.99 | 49.59 | 31.97 |